Bath & Body Works, Inc.BBWI shares are trading lower after the company reported fourth-quarter earnings and issued modest first quarter and FY24 outlook.
The company reported fourth-quarter adjusted earnings per share of $2.06, beating the analyst consensus of $1.87. Quarterly revenues of $2.912 billion beat the street view of $2.84 billion.
Quarterly results gained from strong execution during the holiday season and an extra week in the fourth quarter.
Total sales from U.S. and Canadian stores rose 4% year over year to $2.162 billion, while Direct sales (U.S. and Canada) declined 8% to $656 million. International sales fell 1% to $94 million in the quarter under review.
Gross profit in the quarter under review totaled $1.337 billion, higher than $1.250 billion a year ago. Operating income in the fourth quarter totaled $696 million, higher than $653 million a year ago.
Total Bath & Body Works company-operated stores were 1,850 by February 3, 2024. Bath & Body Works exited the quarter under review with $1.084 billion cash and equivalents. The company’s long-term debt stands at $4.388 billion.
Share Repurchase: The company approved a new share repurchase program to repurchase up to $500 million of the company’s outstanding shares of common stock.
Outlook: Bath & Body Works is forecasting net sales to range between a decline of 3.0% to flat relative to $7.429 billion of net sales in fiscal 2023, resulting in the range of $7.206 billion-$7.429 billion (consensus $7.45 billion. The company projects full-year earnings per share of $3.00-$3.35 versus the $3.34 estimate.
The company’s full-year outlook includes the anticipated impact of approximately $300 million of cash deployed toward share repurchases.
The company expects first-quarter 2024 net sales to decline 4.5% to 2.0% compared to $1.396 billion in 2023, resulting in the range of $1.333 billion-$1.368 billion (consensus $1.38 billion). Bath & Body Works forecasts first-quarter earnings per share of $0.28-$0.33 versus the $0.39 estimate.
Price Action: BBWI shares are trading lower by 8.55% to $44.20 premarket on the last check Thursday.
Photo via Wikimedia Commons
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
